Donald Goff
NYU Langone Health · NYU Langone Medical Center · Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Donald Goff as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05643196 · Focused Ultrasound Modulation of the Globus Pallidus Interna in SchizophreniaNYU Langone Health · completed · Schizophrenia, Schizophrenia Schizoaffective · principal investigator
- Ph2NCT04317807 · R33: Levetiracetam in Early PsychosisNYU Langone Health · completed · Early Psychosis · principal investigator
- N/ANCT03822910 · Hippocampal Memory Circuits in DelusionsNYU Langone Health · completed · Psychosis · principal investigator
- Ph2NCT03129360 · Levetiracetam in Early PsychosisNYU Langone Health · completed · Psychosis, Schizophrenia, Schizo Affective Disorder · principal investigator
- Ph4NCT00611806 · Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of SchizophreniaMassachusetts General Hospital · completed · Schizophrenia · principal investigator
- Ph4NCT00573417 · A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With SchizophreniaNorth Suffolk Mental Health Association · completed · Schizophrenia · principal investigator
- Ph3NCT00403546 · High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia SymptomsDonald C. Goff, MD · completed · Schizophrenia · principal investigator
- Ph3NCT00000372 · Glycine and D-Cycloserine in SchizophreniaMassachusetts General Hospital · withdrawn · Schizophrenia · principal investigator
- Ph3NCT00000371 · Trial of D-Cycloserine in SchizophreniaMassachusetts General Hospital · completed · Schizophrenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- New Treatment and Mechanisms in SchizophreniaK24MH002025 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2001 to 2011 · $188,307 awarded in 2011Same name and institution; not confirmed by an ID
- Folate in SchizophreniaR01MH070831 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2007 to 2010 · $283,500 awarded in 2010Grant number is on one of their registry trials
- Relapse Prevention: Long-Acting Atypical AntipsychoticsU01MH070009 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2006 to 2010 · $170,280 awarded in 2010Same name and institution; not confirmed by an ID
- A TRIAL OF D-CYCLOSERINE IN SCHIZOPHRENIAM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 1996 to 2002 · $200,768 awarded in 2002Same name and institution; not confirmed by an ID
- GLYCINE AND D-CYCLOSERINE IN SCHIZOPHRENIAR01MH057708 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 1998 to 2000 · $118,832 awarded in 2000Same name and institution; not confirmed by an ID
- TRIAL OF D-CYCLOSERINE IN SCHIZOPHRENIAR01MH054245 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 1996 to 1998 · $149,863 awarded in 1998Same name and institution; not confirmed by an ID
- FACULTY SCHOLAR AWARD IN SCHIZOPHRENIAT01MH019053 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 1988 to 1990 · $102,739 awarded in 1990Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:10 UTC. The ranking covers the 200 most relevant of 171 PubMed records, and a shared surname and initials can bring in a namesake. All 171 on PubMed
- Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med · 20085,908 citationsRCR 161.4
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control.N Engl J Med · 20154,851 citationsRCR 187.9
- Effects of intensive blood-pressure control in type 2 diabetes mellitus.N Engl J Med · 20102,673 citationsRCR 77.2
- Effects of combination lipid therapy in type 2 diabetes mellitus.N Engl J Med · 20102,123 citationsRCR 59.7
- Glycemic index of foods: a physiological basis for carbohydrate exchange.Am J Clin Nutr · 19812,075 citationsRCR 71.6
- Effects of medical therapies on retinopathy progression in type 2 diabetes.N Engl J Med · 2010998 citationsRCR 29.6
- 858 citationsRCR 34.9
- Long-term effects of intensive glucose lowering on cardiovascular outcomes.N Engl J Med · 2011766 citationsRCR 21.4
- Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.Am J Psychiatry · 2000573 citationsRCR 17.4
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.Am J Cardiol · 2007500 citationsRCR 12.2